Pacific Biosciences of California PACB Business Segments — Sales and marketing
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:SellingAndMarketingExpense.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's business segments — sales and marketing.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's business segments — sales and marketing?
- Pacific Biosciences of California (PACB) reported business segments — sales and marketing of $15.78M in Q1 2026.
- How has Pacific Biosciences of California's business segments — sales and marketing changed year-over-year?
- Pacific Biosciences of California's business segments — sales and marketing decreased by 21.4% year-over-year, from $20.08M to $15.78M.
- What is the long-term trend for Pacific Biosciences of California's business segments — sales and marketing?
- Over 3 years (2022 to 2025), Pacific Biosciences of California's business segments — sales and marketing has grown at a -4.8% compound annual growth rate (CAGR), from $84.47M to $72.97M.
- What does business segments — sales and marketing mean?
- This represents the costs incurred to promote, sell, and distribute the company's sequencing solutions to clinical and research customers. It reflects the company's investment in market penetration, brand awareness, and the effectiveness of its commercial organization.